| - Industry | - Sector | Mr. Paul Peros CEO | MSE Exchange | INE02WG01016 ISIN |
| Australia Country | - Employees | 3 Mar 2010 Last Dividend | 19 Feb 2020 Last Split | - IPO Date |
Wellfully Limited, originally known as OBJ Limited until its rebranding in September 2020, is an innovative company that is at the forefront of the research and development sphere, focusing on advanced drug delivery technologies. This operation is specifically designed around the principles of Dermaportation and Electrophoresis Transdermal Patch (ETP) technologies. This specialization allows the company to excel in creating sophisticated delivery methods for pharmaceuticals through the skin, making treatments more efficient and user-friendly. Established in 1992 and headquartered in Leederville, Australia, Wellfully Limited not only pioneers in its technical domain but also ensures the industrialization and effective supply-chain integration for its diverse range of products. The company serves a broad spectrum of sectors including pharmaceuticals, cosmetics and skincare, and consumer healthcare, highlighting its versatile approach towards improving health and wellness outcomes through innovative technology.
Wellfully Limited’s portfolio is segmented into two main categories: Dermaportation Drug Delivery Technology and Devices. Each segment represents a facet of the company's commitment to bringing innovative solutions to market.